Details for New Drug Application (NDA): 018333

✉ Email this page to a colleague

NDA 018333 describes CARAFATE, which is a drug marketed by Abbvie and is included in two NDAs. It is available from eleven suppliers. Additional details are available on the CARAFATE profile page.

The generic ingredient in CARAFATE is sucralfate. There are fourteen drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the sucralfate profile page.

Summary for 018333

Tradename:	CARAFATE
Applicant:	Abbvie
Ingredient:	sucralfate
Patents:	0

Pharmacology for NDA: 018333

Medical Subject Heading (MeSH) Categories for 018333

Anti-Ulcer Agents

Suppliers and Packaging for NDA: 018333

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CARAFATE	sucralfate	TABLET;ORAL	018333	NDA AUTHORIZED GENERIC	A-S Medication Solutions	50090-5287	50090-5287-0	60 TABLET in 1 BOTTLE (50090-5287-0)
CARAFATE	sucralfate	TABLET;ORAL	018333	NDA AUTHORIZED GENERIC	Northwind Pharmaceuticals, LLC	51655-475	51655-475-52	30 TABLET in 1 BOTTLE, PLASTIC (51655-475-52)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	1GM
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Expired US Patents for NDA 018333

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	CARAFATE	sucralfate	TABLET;ORAL	018333-001	Approved Prior to Jan 1, 1982	⤷ Get Started Free	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.